Skip to main content

How the government shutdown is affecting biotech companies

The government shutdown is affecting the U.S. Food and Drug Administration’s ability to review new drugs, putting biotech companies in a tough spot.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.